Swiss Rare Disease Registry (SRDR)

ConditionRare Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Bern

About this trial

The SRDR is a national registry that records rare diseases in people of any age who live in Switzerland. It serves as a platform for scientists, health professionals, affected people, and politicians.The SRDR aims to collect epidemiological data on rare diseases, and data on changes to the diagnosis over time. The SRDR will further serve as a research platform and facilitate patient participation in national and international studies. The SRDR will promote harmonization of data and method between the numerous existing disease-specific registries in Switzerland, will strengthen the exchange with international rare disease registries for research and policy, and will build a network for communication for patients and health care providers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosed with a rare disease

High suspicion of a rare disease

Treated or living in Switzerland

Signed informed consent

Disqualifiers

None

Trial population

All individuals with a high suspicion, or a confirmed diagnosis of a rare disease who are treated or living in Switzerland.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

500,000 Participants
are grouped into 1 trial group
Group A: Patient population

Trial outcomes

Primary outcomes

1

Personal Data

Registering patients personal data

Time frame
At diagnosis (age 0-99 years)
2

Diagnosis

Orpha Code of the diagnosed rare disease

Time frame
At diagnosis (age 0-99 years)
3

Date of Diagnosis

Date on which the diagnosis was made

Time frame
At diagnosis (age 0-99 years)
4

Disease History

History of first occurrence of symptoms

Time frame
At registration (age 0-99 years)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Bern

Lead sponsor

Federal Office of Public Health, Switzerland

Collaborator

Universitäts-Kinderspital Zürich

Collaborator

University Children's Hospital Basel

Collaborator

Insel Gruppe AG, University Hospital Bern

Collaborator

University Hospital, Zürich

Collaborator

Centre Hospitalier Universitaire Vaudois

Collaborator

University Hospital, Geneva

Collaborator

Proraris Allianz seltener Krankheiten

Collaborator

Kosek National Coordination Rare Diseases Switzerland

Collaborator

Orphanet Suisse

Collaborator

University of Zurich

Collaborator

Kantonsspital Aarau

Collaborator

Ente Ospedaliero Cantonale, Bellinzona

Collaborator

Cantonal Hospital of St. Gallen

Collaborator

Ostschweizer Kinderspital

Collaborator

University Hospital, Basel, Switzerland

Collaborator

Balgrist University Hospital

Collaborator

Centro Malattie Rare della Svizzera Italiana

Collaborator